Meet Dr. Wink
Hello! I am a wife, mother, psychiatrist, and psychotherapist. I have always been interested in what shapes us—our relationships, our experiences, and the ways we make meaning of our lives. That curiosity continues to guide both my clinical work and my life outside of medicine.
My professional background
I am board-certified in adult, adolescent, and child psychiatry.
After earning a BA in philosophy from St. John’s College, I completed my medical training, psychiatry residency, child and adolescent psychiatry fellowship, and developmental psychiatry fellowship at Indiana University School of Medicine. Alongside my medical training, I developed a particular interest in psychotherapy, completing the Advanced Psychotherapy Training Program and two years of analytic training at the Cincinnati Psychoanalytic Institute.
I spent much of the next decade at Cincinnati Children’s Hospital, where I worked in clinical research developing and studying new medications for use in child psychiatry. While this work gave me a strong foundation in psychopharmacology and evidence-based treatment, psychotherapy has remained at the center of how I understand and practice psychiatry.
In 2019, I founded my private practice with the intention of creating a smaller, more personal kind of psychiatric practice. I have intentionally maintained a limited caseload so that I can offer my patients the time, continuity, and accessibility that I believe are essential to meaningful care.
Since 2024, I have also served as a consultant with Galia Collaborative in Cincinnati, working alongside other clinicians and contributing to a collaborative approach to mental health care.
I continue to deepen my psychotherapy training and clinical thinking. I recently completed the Online Interpersonal Psychoanalytic Psychotherapy Program at the William Alanson White Institute in New York, and in fall 2026 I began the Institute’s program in Eating Disorders, Compulsions, and Addictions.
Outside of work
Outside of work
Outside of the office, I enjoy Pilates, lifting weights, making and looking at art, crocheting, folding paper cranes, listening to music and seeing live shows, and spending time with my family and our dogs and cats on Cincinnati’s east side.
“Excellent diagnostician, psychopharmacologist, and therapist.”
-Dr. Andrew Klafter MD
-
Authoring or co-authoring over 40 peer-reviewed articles, in such journals as the Journal of Child Adolescent Psychopharmacology, Biological Psychiatry, Journal of Autism and Developmental Disorders, Current Psychiatry, Expert Opinion on Investigational Drugs, and the Journal of Child and Adolescent Psychiatry.
Serving as Principal Investigator or Co-investigator/Clinician on 14 grant-funded projects funded by Autism Speaks, Cures Within Reach, Simons Foundation, National Institutes of Health, and the Department of Defense from 2006-2019.
Creating and/or participating in 30+ conference presentations, for conferences sponsored by the American Academy of Child and Adolescent Psychiatry, the American College of Neuropsychopharmacology, and the International meeting for Autism Research.
Accumulating over 8 years of clinical research, clinical practice, and clinical supervision at the #3 Children’s Hospital in the Country.
Completion of the Advanced Psychotherapy Program and 2 years of the Psychoanalytic Trainaing Program at the Cincinnati Psychoanalytic Institute.
-
Wink LK, Reisinger D, Horn P, Shaffer RC, O’Brien K, Schmitt L, Dominick KC, Pedapati EV, Erickson CA, Intranasal Ketamine in Autism Spectrum Disorder: Initial Results of a Randomized, Controlled, Crossover, Pilot Study", Journal of Autism and Developmental Disabilities, JADD-D-19-01142.
Wink LK, Adams R, Horn P, Tessier CR, Bantel AP, Hong M, Shaffer RC, Pedapati EV, Erickson CA.A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder, Journal of Autism and Developmental Disorders, 11 April 2018.
Wink LK, Adams R, Pedapati EV, Dominick KC, Fox E, Buck C, Erickson CA. Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, 26 April 2017.
Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA. Arandomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Molecular Autism, 2016 21 April.
Wink LK, Fitzpatrick S, Shaffer RC, Melnyk S, Schaefer T, Mathieu-Frasier L, Ray B, Lahiri D, Erickson CA. The Neurobehavioral and Molecular Phenotype of Angelman Syndrome, American Journal of Medical Genetics Part A, 2015 Jul 29.
Wink LK, Early MC, Schaefer T, Bermingham R, Pottenger A, Horn P, McDougle CJ, Erickson CA: Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole. Journal of Child and Adolescent Psychopharmacology, 2014 Feb 24.
Wink LK, Erickson CA,Chambers JE, McDougle CJ: Co-morbid intellectual disability and borderline personality disorder: A case series. Psychiatry, 73(3): 279-289, 2010.